IL22 and inflammatory bowel disease: With respect to T cell-induced colitis, no significant difference has been reported between RAG1−/− mice that received CD45RBhighIL-22+/+ or CD45RBhighIL-22−/− CD4+ T cells, indicating that the mice rely on a host-derived source of IL-22 during IBD development (96).